Onyx explores possible sale after rejecting Amgen offer

dimanche 30 juin 2013

Cancer drugmaker Onyx Pharmaceuticals Inc said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen Inc as too low but still is considering selling itself. ...



via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-explores-possible-sale-rejecting-001519769.html

0 commentaires:

Enregistrer un commentaire